Summary Infection with SARS‐CoV‐2, the etiology of the ongoing COVID‐19 pandemic, has
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …

Background Although biological males and females are equally likely to become infected
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evidence has …

There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …

Background Easily distributed oral antivirals are urgently needed to treat coronavirus
disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of …

Elucidating the characteristics of human immune response against SARS-CoV-2 is of high
priority and relevant for determining vaccine strategies. We report the results of a follow-up …

Background As vaccine supply and access remain limited in many parts of the world,
understanding the duration of protection from reinfection after natural infection is important …

Durability of SARS-CoV-2 Spike antibody responses after infection provides information
relevant to understanding protection against COVID-19 in humans. We report the results of a …

Background Given the importance of vaccination against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) in the prevention of severe coronavirus disease 2019 (COVID …

Host response to COVID-19 vaccines is partially evaluated through the estimation of
antibody response, specifically the binding anti-spike (anti-S) and the neutralizing …

Laboratory testing has been a key tool in managing the SARS-CoV-2 global pandemic.
While rapid antigen and PCR testing has proven useful for diagnosing acute SARS-CoV-2 …